Cargando…

A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells

BRCA1 or BRCA2 germline mutations predispose to breast, ovarian and other cancers. High-throughput sequencing of tumour genomes revealed that oncogene amplification and BRCA1/2 mutations are mutually exclusive in cancer, however the molecular mechanism underlying this incompatibility remains unknown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dagg, Rebecca A., Zonderland, Gijs, Lombardi, Emilia Puig, Rossetti, Giacomo G., Groelly, Florian J., Barroso, Sonia, Tacconi, Eliana M. C., Wright, Benjamin, Lockstone, Helen, Aguilera, Andrés, Halazonetis, Thanos D., Tarsounas, Madalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363664/ https://www.ncbi.nlm.nih.gov/pubmed/34389725 http://dx.doi.org/10.1038/s41467-021-25215-0

Ejemplares similares

High-resolution mapping of mitotic DNA synthesis under conditions of replication stress in cultured cells
por: Groelly, Florian J., et al.
Publicado: (2023)

Mitotic DNA synthesis is caused by transcription-replication conflicts in BRCA2-deficient cells
por: Groelly, Florian J., et al.
Publicado: (2022)

BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors
por: Reisländer, Timo, et al.
Publicado: (2019)

BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity
por: Tacconi, Eliana MC, et al.
Publicado: (2017)

Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
por: Zimmer, Jutta, et al.
Publicado: (2016)

Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours
por: Groelly, Florian J, et al.
Publicado: (2022)

A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
por: Chaikuad, Apirat, et al.
Publicado: (2014)

Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress
por: Macheret, Morgane, et al.
Publicado: (2018)

FANCD2 limits replication stress and genome instability in cells lacking BRCA2
por: Michl, Johanna, et al.
Publicado: (2016)

BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres
por: Badie, Sophie, et al.
Publicado: (2015)

MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells
por: Lai, Xianning, et al.
Publicado: (2017)

Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice
por: Lemberger, Ursula J., et al.
Publicado: (2018)

Corrigendum: MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells
por: Lai, Xianning, et al.
Publicado: (2017)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
por: Tacconi, Eliana MC, et al.
Publicado: (2019)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Bajrami, Ilirjana, et al.
Publicado: (2021)

BRCA2 Acts as RAD51 Loader to Facilitate Telomere Replication and Capping
por: Badie, Sophie, et al.
Publicado: (2010)

Interplay between Fanconi anemia and homologous recombination pathways in genome integrity
por: Michl, Johanna, et al.
Publicado: (2016)

53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
por: Bouwman, Peter, et al.
Publicado: (2010)

Emerging common themes in regulation of PIKKs and PI3Ks
por: Lempiäinen, Harri, et al.
Publicado: (2009)

DNA replication stress as an Achilles' heel of cancer
por: Da-Rè, Caterina, et al.
Publicado: (2014)

Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes
por: Dionellis, Vasilis S., et al.
Publicado: (2021)

Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?
por: McAllister, Kimberly A, et al.
Publicado: (2002)

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
por: Ratz, Leonie, et al.
Publicado: (2022)

Rad51 and Dmc1 Form Mixed Complexes Associated with Mouse Meiotic Chromosome Cores and Synaptonemal Complexes
por: Tarsounas, Madalena, et al.
Publicado: (1999)

Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1
por: Petalcorin, MIR, et al.
Publicado: (2006)

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer
por: Wicha, Max S
Publicado: (2009)

PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency
por: Noll, Aurélia, et al.
Publicado: (2016)

Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer
por: Hu, Yunlong, et al.
Publicado: (2020)

A Model to Investigate Single-Strand DNA Responses in G1 Human Cells via a Telomere-Targeted, Nuclease-Deficient CRISPR-Cas9 System
por: Crefcoeur, Remco P., et al.
Publicado: (2017)

Covalent Degrader of the Oncogenic Transcription Factor β-Catenin
por: Gowans, Flor A., et al.
Publicado: (2023)

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene induced senescence
por: Sulli, Gabriele, et al.
Publicado: (2018)

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
por: Oei, Arlene L., et al.
Publicado: (2017)

β-Catenin: oncogenic role and therapeutic target in cervical cancer
por: Wang, Bingqi, et al.
Publicado: (2020)

Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1
por: Chang, Suhwan, et al.
Publicado: (2012)

Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors
por: Lappin, Katrina M., et al.
Publicado: (2022)

RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation
por: Badie, Sophie, et al.
Publicado: (2009)

MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers
por: Srinivasan, Gayathri, et al.
Publicado: (2019)

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
por: Zatreanu, Diana, et al.
Publicado: (2021)

P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks
por: Schultz, Linda B., et al.
Publicado: (2000)

Ubiquitin-H2AX fusions render 53BP1 recruitment to DNA damage sites independent of RNF8 or RNF168
por: Kocyłowski, Maciej K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2hdtkqouesolo0gbbevd48oj0s